Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Update: 2025-01-09

Description

The pivotal role of programmed death-ligand 1 (PD-L1) checkpoint inhibition for treating advanced melanoma has been confirmed in findings from the KEYNOTE-006 study comparing the anti-PD-L1 antibody pembrolizumab immunotherapy with the anti-cytotoxic T-lymphocyte associated protein 4 (CTLA-4) drug ipilimumab for treating patients with unresectable advanced or metastatic melanoma. Results from the study were reported at the European Society for Medical Oncology (ESMO) 2024 Annual Congress, held in Barcelona, Spain.

Comments

In Channel

From Ironman to Advocate: Tom Hulsey’s Journey Through Prostate Cancer and Purpose

2025-08-0126:12

Accurate and Actionable: How Oncologists Get Fast, Comprehensive Therapeutic Insights from the OncoExTra® Test

2025-07-1719:37

Empowering Cancer Care Through Movement: A Conversation with Sami Mansfield

2025-07-0135:19

Defying the Odds: Katie Coleman's Journey from Diagnosis to Advocacy

2025-06-0229:33

Making Comprehensive Genomic Profiling More Accurate for Everyone: The Importance of Patient-Matched Tumor-Normal Sequencing

2025-05-2812:33

Transforming colorectal cancer management with tumor informed ctDNA testing

2025-05-2214:25

Lessons in Resilience: Dr. Susan MacDonald's Healthcare Journey

2025-05-0223:54

Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities at High Risk

2025-03-2712:53

Striking Microbiome Bacterial Population Differences Distinguish Metastatic Prostate Cancer From Non-Metastatic Disease

2025-03-0308:40

Adjuvant Androgen Deprivation Therapy No Benefit After Surgery for High-Risk Prostate Cancer

2025-03-0309:41

Novel Score Selects Patients With Intermediate Risk Prostate Cancer Safe for Active Surveillance

2025-03-0310:08

Mobile Prostate Cancer Screening Clinic Raises Prostate Cancer Early Detection Rates in Underserved Communities

2025-03-0312:53

Episode 3, Better Informed Patient Journeys

2025-02-2611:16

Episode 2, HRD Testing Deep-Dive

2025-02-2607:23

Episode 1, A Precision Medicine Approach for Advanced Ovarian Cancer

2025-02-2616:40

KEYNOTE-006 Study 10-Year Survival Data Confirm PD-L1 Checkpoint Inhibition Best for Patients With Advanced Melanoma

2025-01-2407:33

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

2025-01-1316:09

Tumor-Agnostic Classifier & Screener Aids Targeted Drug Development

2025-01-1009:21

Early Switch to Immunotherapy Recommended After BRAFV600 Mutation Targeted Therapy for Advanced Melanoma

2025-01-1007:25

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

2025-01-0907:33

00:00

1.0x

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

#box-pro-ellipsis-17591525227298{-webkit-line-clamp:2;}Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified

Microsatellite Unstable Colorectal Cancers: Key Gene Mutation for Werner Helicase Inhibitor Resistance Identified